Proheptazine

This classification denotes an analgesic agent with the molecular formula C17H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S23189WW7E, chemically known as 1,3-dimethyl-4-phenyl-4-propionyloxyazacycloheptane but generally known as proheptazine, which bears US NIH Compound Identifier 60969. European Medicines Agency schedules Proheptazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10080MIG. The term PROHEPTAZINE is an International Non-Proprietary Name. PROHEPTAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proheptazine under HS 29339990 and SITC 51577. As of Q4 2014, PROHEPTAZINE remains the US FDA Preferred Term for this commodity. Proheptazine bears US NLM identifiers UMLS ID C1882476 and NCI Concept Code C66477. SMILES: O(C1(C(CN(CCC1)C)C)C1CCCCC1)C(=O)CC.